# Corporate-Finance-project


This is a final group report for our Corporate Finance course.
Description:
- Conducted comprehensive financial analysis of Imexpharm (IMP) using 4-year data, including balance sheet, income statement, and key financial ratios.
- Forecasted revenue, costs, and earnings over 3 years using quantitative models and scenario analysis.
- Built a financial model in Excel to estimate future performance and assess risk under best- and worst-case scenarios.
- Evaluated profitability, liquidity, and valuation metrics to provide investment insights and strategic recommendations.

ðŸ“„ [Download the full PDF report here](https://github.com/user-attachments/files/21391232/IMP.Financial.analysis.Forecasting_Written.report.pdf)
